Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ai-Ris Y Collier

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Frontiers in Immunology|November 17, 2022
Pan-neutralizing, germline-encoded antibodies against SARS-CoV-2: Addressing the long-term problem of escape variantsJustin Mark Lunderberg, Sanjucta Dutta, Ai-Ris Y Collier, et al.
Medrxiv : the Preprint Server for Health Sciences|February 16, 2022
Comparable Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 VariantsJingyou Yu, Ai-Ris Y Collier, Marjorie Rowe, et al.
The New England Journal of Medicine|March 16, 2022
Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 VariantsJingyou Yu, Ai-Ris Y Collier, Marjorie Rowe, et al.
JAMA Network Open|February 19, 2025
Maternal RSVpreF and Infant Nirsevimab Immunizations Uptake During Respiratory Syncytial Virus SeasonEthan A Litman, Tina Yi Jin Hsieh, Anna M Modest, et al.
Science Translational Medicine|October 23, 2024
SARS-CoV-2 XBB.1.5 mRNA booster vaccination elicits limited mucosal immunityNinaad Lasrado, Marjorie Rowe, Katherine McMahan, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2025
Contrasting Effects of SARS-CoV-2 Vaccination vs. Infection on Antibody and TCR RepertoiresJasper Braun, Elliot D Hill, Elisa Contreras, et al.
JAMA|March 9, 2026
Vaccine-Elicited Antibody Responses to Influenza A(H3N2) Subclade KLiping Wang, Samuel J Nangle, Alejandra Waller-Pulido, et al.
Journal of Virology|April 24, 2021
Correlates of Neutralization against SARS-CoV-2 Variants of Concern by Early Pandemic SeraSamuel J Vidal, Ai-Ris Y Collier, Jingyou Yu, et al.
Vaccine|October 23, 2023
Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86Ninaad Lasrado, Ai-Ris Y Collier, Nicole P Hachmann, et al.
Medrxiv : the Preprint Server for Health Sciences|May 25, 2021
Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19Alec A Schmaier, Gabriel Pajares Hurtado, Zachary J Manickas-Hill, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|November 17, 2022
Pan-neutralizing, germline-encoded antibodies against SARS-CoV-2: Addressing the long-term problem of escape variantsJustin Mark Lunderberg, Sanjucta Dutta, Ai-Ris Y Collier, et al.
Medrxiv : the Preprint Server for Health Sciences|February 16, 2022
Comparable Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 VariantsJingyou Yu, Ai-Ris Y Collier, Marjorie Rowe, et al.
The New England Journal of Medicine|March 16, 2022
Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 VariantsJingyou Yu, Ai-Ris Y Collier, Marjorie Rowe, et al.
JAMA Network Open|February 19, 2025
Maternal RSVpreF and Infant Nirsevimab Immunizations Uptake During Respiratory Syncytial Virus SeasonEthan A Litman, Tina Yi Jin Hsieh, Anna M Modest, et al.
Science Translational Medicine|October 23, 2024
SARS-CoV-2 XBB.1.5 mRNA booster vaccination elicits limited mucosal immunityNinaad Lasrado, Marjorie Rowe, Katherine McMahan, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2025
Contrasting Effects of SARS-CoV-2 Vaccination vs. Infection on Antibody and TCR RepertoiresJasper Braun, Elliot D Hill, Elisa Contreras, et al.
JAMA|March 9, 2026
Vaccine-Elicited Antibody Responses to Influenza A(H3N2) Subclade KLiping Wang, Samuel J Nangle, Alejandra Waller-Pulido, et al.
Journal of Virology|April 24, 2021
Correlates of Neutralization against SARS-CoV-2 Variants of Concern by Early Pandemic SeraSamuel J Vidal, Ai-Ris Y Collier, Jingyou Yu, et al.
Vaccine|October 23, 2023
Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86Ninaad Lasrado, Ai-Ris Y Collier, Nicole P Hachmann, et al.
Medrxiv : the Preprint Server for Health Sciences|May 25, 2021
Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19Alec A Schmaier, Gabriel Pajares Hurtado, Zachary J Manickas-Hill, et al.
Pageof 6